TB “host-directed therapy” finds novel target

Researchers from the faculty of medicine at the University of Ottawa and their international collaborators say they have shown proof-of-concept for a new therapeutic approach in treating tuberculosis (TB). The disease is caused by a bacterium, Mycobacterium tuberculosis, that infects the lungs and is highly transmissible when infected people cough or sneeze.